Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

Grundium acquires Visiopharm

Grundium, a Finland-based digital pathology imaging company backed by US private equity firm EW Healthcare Partners, has acquired Denmark-based AI precision pathology software provider Visiopharm. The deal aims to create an integrated digital pathology platform combining imaging and AI-driven diagnostics.

Permira exits Australian radiology network I-MED

London-based private equity firm Permira has agreed to sell I-MED Radiology Network, Australia’s largest diagnostic imaging provider, to Jardine Matheson, a London-and-Singapore-listed conglomerate, for A$3.4 billion (~US$2.4 billion). The transaction also includes Permira’s stake in Harrison.ai, a medical imaging AI company.

Medtronic acquires SPR Therapeutics

Listed Irish-American medtech giant Medtronic is buying Ohio-based SPR Therapeutics for about $650 million in cash. SPR makes minimally invasive devices for the treatment of chronic pain.

Avista and Damier acquire Sanotact

American private equity firm Avista Healthcare Partners and and Belgium-based family office Damier Group will acquire German vitamins, minerals, and supplements (VMS) platform Sanotact Group from the investment arm of the Piëch-Nordhoff family, FLOTTE.

Bregal Sagemount and Ardian invest in Ennov

Ennov, a France-based life sciences software company, has secured a growth investment led by US private equity firm Bregal Sagemount, with participation from private investment firm Ardian.

CVC and GBL launch €10.7 bn take-private offer for Recordati

Luxembourg-based private equity firm CVC Capital, through CVC Fund IX, and Belgian investment firm Groupe Bruxelles Lambert (GBL) have launched a €10.7 billion ($12.4 ‌billion) cash offer for all outstanding ordinary shares to take Italian pharmaceutical firm Recordati private. 

CMA accepts Welltower’s offer to offload certain UK care homes

The UK Competition and Markets Authority (CMA) has provisionally accepted US healthcare REIT Welltower’s offer to divest certain care homes out of the 600+ it bought last year. The CMA had raised concerns about the impact on local competition dynamics in certain areas where a large portion of the care homes would now be owned by Welltower.

Healthcare deal activity expected to be increasingly back-end loaded through 2026: Hedley Goldberg, Rothschild & Co

The global healthcare M&A landscape in 2026 sits at an unusual juncture. The wider economy is facing a lot of headwinds and feels increasingly uncertain, whilst the usual private equity strategies aren’t working as smoothly as before. Healthcare is still seen as one of the strongest sectors to invest in around the world, however, and may even benefit from the shift away from software and tech-enabled services. 

Find Us